Log on / register
Feedback | Support | My details

Email this article to a friend

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial

Kenneth Rockwood email, Sherri Fay email, Mary Gorman email, Daniel Carver email and Janice E Graham email

BMC Neurology 2007, 7:26doi:10.1186/1471-2377-7-26

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated